Solu-Medrol Drug Interactions: 4 Major, 188 Moderate
Solu-Medrol (Methylprednisolone Sodium Succinate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Solu-Medrol. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Acarbose.
Level 1 evidence
Acenocoumarol
Methylprednisolone hemisuccinate may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Methylprednisolone hemisuccinate is combined with Acetylsalicylic acid.
Level 1 evidence
Albuterol
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Albuterol.
Level 2 evidence
Almasilate
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Almasilate.
Level 2 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Alogliptin.
Level 1 evidence
Aluminium phosphate
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Aluminium phosphate.
Level 2 evidence
Aluminum hydroxide
The bioavailability of Methylprednisolone hemisuccinate can be decreased when combined with Aluminum hydroxide.
Level 2 evidence
Amphotericin B
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Amphotericin B.
Level 1 evidence
Arformoterol
The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Arformoterol.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Methylprednisolone hemisuccinate is combined with Articaine.
Level 1 evidence
Atracurium besylate
The risk or severity of myopathy and weakness can be increased when Atracurium besylate is combined with Methylprednisolone hemisuccinate.
Level 2 evidence
Enter your NPI to unlock 2 major interactions for Solu-Medrol
Solu-Medrol (Methylprednisolone Sodium Succinate) has 264 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Solu-Medrol (Methylprednisolone Sodium Succinate) has 4 major, 188 moderate, and 72 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Solu-Medrol. Always confirm against the full prescribing information.